Japanese Encephalitis Vaccine

166 The Hon. N.J. CENTOFANTI (Leader of the Opposition) ().21 October 2022).

1. What is the total funding provided by the commonwealth to SA Health for the purchase of Japanese encephalitis vaccines for human mitigation purposes since 1 January 2022?

2. What is the total value of Japanese encephalitis vaccines purchased by SA Health for human mitigation purposes since 1 January 2022?

3. Is SA Health administering a Japanese encephalitis vaccine program through its local health networks or has a third party/parties been engaged to administer the vaccine program?

4. How many Japanese encephalitis vaccines have been administered in South Australia since 1 January 2022?

5. How many Japanese encephalitis vaccines are estimated to be administered in the financial year 2022-23?

The Hon. K.J. MAHER (Minister for Aboriginal Affairs, Attorney-General, Minister for Industrial Relations and Public Sector): The Minister for Health and Wellbeing has advised:

The total funding provided by the commonwealth to SA Health for the purchase of Japanese encephalitis vaccines for human mitigation purposes since 1 January 2022 is $5.1 million (including GST).

The total value of Japanese encephalitis vaccines purchased by SA Health for human mitigation purposes since 1 January 2022 is $1.5 million (including GST).

SA Health is administering the Japanese encephalitis vaccination program through its Local Health Networks, participating GPs and pharmacies in the eligible zones. The engagement of third parties will be used if additional staffing and clinics are required due to vaccine demand.

Since 1 January 2022, approximately 21,250 Japanese encephalitis vaccines have been administered in South Australia.

Currently, up to 24,000 Japanese encephalitis vaccines have been made available for the program and the aim is to administer most of these within the 2022-23 financial year.